DOCSLIB.ORG

Suppementary Table 9. Predicted Targets of Hsa-Mir-181A by Targetscan 6.2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Suppementary Table 9. Predicted Targets of Hsa-Mir-181A by Targetscan 6.2 Suppementary Table 9. Predicted targets of hsa-miR-181a by TargetScan 6.2. Total Aggregate Cancer Target Gene ID Gene name context+ P gene score CT ABL2 NM_001136000 V-abl Abelson murine leukemia viral oncogene homolog 2 > -0.03 0.31 √ ACAN NM_001135 Aggrecan -0.09 0.12 ACCN2 NM_001095 Amiloride-sensitive cation channel 2, neuronal > -0.01 0.26 ACER3 NM_018367 Alkaline ceramidase 3 -0.04 <0.1 ACVR2A NM_001616 Activin A receptor, type IIA -0.16 0.64 ADAM metallopeptidase with thrombospondin type 1 ADAMTS1 NM_006988 > -0.02 0.42 motif, 1 ADAM metallopeptidase with thrombospondin type 1 ADAMTS18 NM_199355 -0.17 0.64 motif, 18 ADAM metallopeptidase with thrombospondin type 1 ADAMTS5 NM_007038 -0.24 0.59 motif, 5 ADAMTSL1 NM_001040272 ADAMTS-like 1 -0.26 0.72 ADARB1 NM_001112 Adenosine deaminase, RNA-specific, B1 -0.28 0.62 AFAP1 NM_001134647 Actin filament associated protein 1 -0.09 0.61 AFTPH NM_001002243 Aftiphilin -0.16 0.49 AK3 NM_001199852 Adenylate kinase 3 > -0.02 0.6 AKAP7 NM_004842 A kinase (PRKA) anchor protein 7 -0.16 0.37 ANAPC16 NM_001242546 Anaphase promoting complex subunit 16 -0.1 0.66 ANK1 NM_000037 Ankyrin 1, erythrocytic > -0.03 0.46 ANKRD12 NM_001083625 Ankyrin repeat domain 12 > -0.03 0.31 ANKRD33B NM_001164440 Ankyrin repeat domain 33B -0.17 0.35 ANKRD43 NM_175873 Ankyrin repeat domain 43 -0.16 0.65 ANKRD44 NM_001195144 Ankyrin repeat domain 44 -0.17 0.49 ANKRD52 NM_173595 Ankyrin repeat domain 52 > -0.05 0.7 AP1S3 NM_001039569 Adaptor-related protein complex 1, sigma 3 subunit -0.26 0.76 Amyloid beta (A4) precursor protein-binding, family A, APBA1 NM_001163 -0.13 0.81 member 1 APLP2 NM_001142276 Amyloid beta (A4) precursor-like protein 2 -0.05 0.55 APOO NM_024122 Apolipoprotein O -0.32 0.41 ARID2 NM_152641 AT rich interactive domain 2 (ARID, RFX-like) -0.07 0.55 √ ARL3 NM_004311 ADP-ribosylation factor-like 3 > -0.03 0.51 ARRDC3 NM_020801 Arrestin domain containing 3 > -0.02 0.47 ATF7 NM_001130059 Activating transcription factor 7 > -0.01 0.26 ATG2B NM_018036 ATG2 autophagy related 2 homolog B (S. Cerevisiae) > -0.02 0.61 ATG7 NM_001136031 ATG7 autophagy related 7 homolog (S. Cerevisiae) -0.03 0.61 ATP11A NM_015205 ATPase, class VI, type 11A > -0.04 0.79 ATP2B3 NM_001001344 ATPase, Ca++ transporting, plasma membrane 3 -0.11 0.25 √ ATP8B2 NM_020452 ATPase, class I, type 8B, member 2 > -0.01 0.53 ATXN1 NM_000332 Ataxin 1 > -0.06 0.88 √ ATXN7 NM_000333 Ataxin 7 -0.19 0.77 UDP-Gal:betaglcnac beta 1,4- galactosyltransferase, B4GALT1 NM_001497 -0.12 0.69 polypeptide 1 BAG4 NM_001204878 BCL2-associated athanogene 4 -0.27 0.64 BAI3 NM_001704 Brain-specific angiogenesis inhibitor 3 -0.19 0.68 BCL2 NM_000633 B-cell CLL/lymphoma 2 > -0.04 0.83 √ BCL9 NM_004326 B-cell CLL/lymphoma 9 -0.03 0.32 √ BCR NM_004327 Breakpoint cluster region > -0.01 0.34 BHLHE40 NM_003670 Basic helix-loop-helix family, member e40 -0.3 0.77 BMF NM_001003940 Bcl2 modifying factor -0.01 0.53 BNC2 NM_017637 Basonuclin 2 > -0.03 0.39 BRD1 NM_014577 Bromodomain containing 1 -0.22 0.47 BRWD1 NM_033656 Bromodomain and WD repeat domain containing 1 -0.32 0.9 BTBD3 NM_014962 BTB (POZ) domain containing 3 -0.39 0.95 C10orf46 NM_153810 Chromosome 10 open reading frame 46 N/A 0.73 C11orf30 NM_020193 Chromosome 11 open reading frame 30 -0.15 0.42 C11orf75 NM_020179 Chromosome 11 open reading frame 75 -0.04 0.61 C12orf68 NM_001013635 Chromosome 12 open reading frame 68 > -0.02 0.36 C13orf23 NM_025138 Chromosome 13 open reading frame 23 -0.17 0.61 C13orf30 NM_182508 Chromosome 13 open reading frame 30 > -0.02 0.63 C14orf43 NM_001043318 Chromosome 14 open reading frame 43 -0.23 0.76 C17orf63 NM_001077498 Chromosome 17 open reading frame 63 > -0.03 0.65 Core 1 synthase, glycoprotein-N-acetylgalactosamine 3- C1GALT1 NM_020156 -0.12 0.76 beta-galactosyltransferase, 1 C3orf43 NM_001077657 Chromosome 3 open reading frame 43 -0.16 0.22 C3orf62 NM_198562 Chromosome 3 open reading frame 62 -0.18 0.38 C6orf192 NM_052831 Chromosome 6 open reading frame 192 -0.15 0.46 C6orf35 NM_018452 Chromosome 6 open reading frame 35 -0.3 0.8 Calcium channel, voltage-dependent, alpha 2/delta subunit CACNA2D2 NM_001005505 > -0.02 0.76 2 CALR NM_004343 Calreticulin -0.07 0.34 √ CAMSAP1L1 NM_203459 Calmodulin regulated spectrin-associated protein 1-like 1 -0.18 0.34 CAMTA2 NM_001171166 Calmodulin binding transcription activator 2 -0.1 0.33 CAPRIN1 NM_203364 Cell cycle associated protein 1 -0.3 0.63 CARM1 NM_199141 Coactivator-associated arginine methyltransferase 1 -0.12 0.67 CASP10 NM_001206524 Caspase 10, apoptosis-related cysteine peptidase > -0.03 0.25 Core-binding factor, runt domain, alpha subunit 2; CBFA2T3 NM_005187 -0.24 0.6 √ translocated to, 3 Cas-Br-M (murine) ecotropic retroviral transforming CBLB NM_170662 -0.24 0.33 √ sequence b Cas-Br-M (murine) ecotropic retroviral transforming CBLL1 NM_024814 -0.19 0.51 sequence-like 1 CBX4 NM_003655 Chromobox homolog 4 -0.29 0.69 CBX5 NM_001127321 Chromobox homolog 5 > -0.03 0.7 CCDC117 NM_173510 Coiled-coil domain containing 117 > -0.03 0.56 CCDC141 NM_173648 Coiled-coil domain containing 141 > -0.02 0.48 CCDC17 NM_001114938 Coiled-coil domain containing 17 N/A 0.35 CCDC6 NM_005436 Coiled-coil domain containing 6 > -0.03 0.62 √ CCDC64 NM_207311 Coiled-coil domain containing 64 > -0.01 0.58 CCDC90A NM_001031713 Coiled-coil domain containing 90A > -0.03 < 0.1 CCL8 NM_005623 Chemokine (C-C motif) ligand 8 -0.23 <0.1 CCNG1 NM_004060 Cyclin G1 -0.17 <0.1 CCNJ NM_001134375 Cyclin J -0.16 0.69 CCNK NM_001099402 Cyclin K -0.23 0.72 CCNT2 NM_001241 Cyclin T2 -0.22 0.1 CD4 NM_000616 CD4 molecule -0.17 0.55 CD69 NM_001781 CD69 molecule -0.15 0.41 CDC27 NM_001114091 Cell division cycle 27 homolog (S. Cerevisiae) -0.04 0.34 Cell division cycle 73, Paf1/RNA polymerase II complex CDC73 NM_024529 -0.22 0.4 √ component, homolog (S. Cerevisiae ) CDH13 NM_001220488 Cadherin 13, H-cadherin (heart) -0.11 0.47 CDK8 NM_001260 Cyclin-dependent kinase 8 -0.07 0.34 CDKL2 NM_003948 Cyclin-dependent kinase-like 2 (CDC2-related kinase) -0.14 0.66 CDON NM_016952 Cdon homolog (mouse) -0.34 0.81 CDYL NM_001143970 Chromodomain protein, Y-like -0.24 0.32 CEBPA NM_004364 CCAAT/enhancer binding protein (C/EBP), alpha > -0.02 0.49 √ Cadherin, EGF LAG seven-pass G-type receptor 3 CELSR3 NM_001407 > -0.01 0.41 (flamingo homolog, Drosophila) CEP350 NM_014810 Centrosomal protein 350kda > -0.03 0.33 CHD1 NM_001270 Chromodomain helicase DNA binding protein 1 -0.05 0.34 CHD7 NM_017780 Chromodomain helicase DNA binding protein 7 -0.05 0.69 CHD9 NM_025134 Chromodomain helicase DNA binding protein 9 -0.11 0.54 CHIC1 NM_001039840 Cysteine-rich hydrophobic domain 1 -0.09 0.44 CHMP1B NM_020412 Chromatin modifying protein 1B -0.31 0.59 CLCC1 NM_001048210 Chloride channel CLIC-like 1 -0.1 0.41 CLIP1 NM_002956 CAP-GLY domain containing linker protein 1 -0.33 0.49 CLMN NM_024734 Calmin (calponin-like, transmembrane) -0.33 0.78 CLVS1 NM_173519 Clavesin 1 -0.43 0.59 CNKSR2 NM_001168647 Connector enhancer of kinase suppressor of Ras 2 -0.06 0.65 CNKSR3 NM_173515 CNKSR family member 3 -0.27 0.47 CNOT6L NM_144571 CCR4-NOT transcription complex, subunit 6-like > -0.05 0.44 CNR1 NM_001160226 Cannabinoid receptor 1 (brain) -0.08 0.53 CNTN4 NM_001206955 Contactin 4 -0.16 <0.1 CNTNAP2 NM_014141 Contactin associated protein-like 2 -0.16 0.81 COL5A1 NM_000093 Collagen, type V, alpha 1 > -0.02 0.37 COMMD6 NM_203495 COMM domain containing 6 -0.1 0.55 COP9 constitutive photomorphogenic homolog subunit 2 COPS2 NM_001143887 -0.13 0.83 (Arabidopsis) CPD NM_001199775 Carboxypeptidase D > -0.05 0.67 CPT1A NM_001876 Carnitine palmitoyltransferase 1A (liver) -0.23 0.29 CREBL2 NM_001310 Camp responsive element binding protein-like 2 > -0.04 0.49 √ Cysteine rich transmembrane BMP regulator 1 (chordin- CRIM1 NM_016441 > -0.03 0.6 like) CRISPLD1 NM_031461 Cysteine-rich secretory protein LCCL domain containing 1 -0.13 0.54 CSNK1G3 NM_001031812 Casein kinase 1, gamma 3 -0.1 0.58 CSRNP3 NM_001172173 Cysteine-serine-rich nuclear protein 3 > -0.03 0.54 CTD (carboxy-terminal domain, RNA polymerase II, CTDSPL NM_001008392 -0.37 0.95 polypeptide A) small phosphatase-like CTIF NM_001142397 CBP80/20-dependent translation initiation factor > -0.03 0.37 CTTNBP2NL NM_018704 CTTNBP2 N-terminal like -0.22 0.96 CUL3 NM_003590 Cullin 3 -0.06 0.89 CUL4A NM_001008895 Cullin 4A -0.04 0.25 CXADR NM_001207063 Coxsackie virus and adenovirus receptor > -0.04 0.7 CYLD NM_001042355 Cylindromatosis (turban tumor syndrome) -0.06 0.57 √ DCP1A NM_018403 DCP1 decapping enzyme homolog A (S. Cerevisiae) > -0.01 0.26 DCP2 NM_001242377 DCP2 decapping enzyme homolog (S. Cerevisiae) > -0.01 0.28 DDIT4 NM_019058 DNA-damage-inducible transcript 4 -0.18 0.62 DDX3X NM_001193416 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked -0.34 0.98 DDX3Y NM_001122665 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked -0.36 0.66 DEPTOR NM_022783 DEP domain containing MTOR-interacting protein -0.24 0.64 DERL1 NM_001134671 Der1-like domain family, member 1 -0.21 0.69 DGCR2 NM_001173533 Digeorge syndrome critical region gene 2 > -0.02 0.65 DIP2A NM_001146116 DIP2 disco-interacting protein 2 homolog A (Drosophila) > -0.01 0.31 DIP2B NM_173602 DIP2 disco-interacting protein 2 homolog B (Drosophila) -0.16 0.73 DIP2C NM_014974 DIP2 disco-interacting protein 2 homolog C (Drosophila) -0.1 0.61 DLG2 NM_001142699 Discs, large homolog 2 (Drosophila) -0.07 0.59 DLGAP2 NM_004745 Discs, large (Drosophila) homolog-associated protein 2 -0.12 0.93 DMXL2 NM_001174116 Dmx-like 2 -0.16 0.85 DNAJA4 NM_001130182 Dnaj (Hsp40) homolog, subfamily A, member 4 -0.26 0.47 DNAL1 NM_001201366
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0237501 A1 SHARP Et Al
    US 2016O23750 1A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0237501 A1 SHARP et al. (43) Pub. Date: Aug. 18, 2016 (54) BIOMARKERS FOR DIAGNOSIS OF Related U.S. Application Data TRANSIENT SCHEMICATTACKS (62) Division of application No. 13/182,630, filed on Jul. (71) Applicant: The Regents of the University of 14, 2011, now abandoned. California, Oakland, CA (US) (60) Provisional application No. 61/364.334, filed on Jul. 14, 2010. (72) Inventors: Frank SHARP, Davis, CA (US); Xinhua ZHAN. Vacaville, CA (US); Publication Classification Glen C. JICKLING, Sacramento, CA (US): S. Claiborne JOHNSTON, San (51) Int. Cl. Francisco, CA (US) CI2O I/68 (2006.01) (52) U.S. Cl. (73) Assignee: The Regents of the University of CPC ........ CI2O 1688 (2013.0); CI2O 2600/158 California, Oakland, CA (US) (2013.01); C12O 2600/1 18 (2013.01) (57) ABSTRACT (21) Appl. No.: 15/043,577 The present invention provides methods and compositions for diagnosing and predicting the risk and cause of transient (22) Filed: Feb. 14, 2016 ischemic attacks (TIA). Patent Application Publication Aug. 18, 2016 Sheet 1 of 4 US 2016/0237SO1 A1 Standardized intensity s sis: iagnosis Controls xIA Figure IA-B Patent Application Publication Aug. 18, 2016 Sheet 2 of 4 US 2016/0237SO1 A1 & TA Cross-validated Probabilities (Thresholds 0.89) * Controls Controls TA ----------------------------------------------------------------------------------------------------------------------------------------- ... 0.9 O.8 O O 20 Subjects30 40 SO 50 Figure 2 Patent Application Publication Aug. 18, 2016 Sheet 3 of 4 US 2016/0237SO1 A1 Cross-validated Probabilities (Threshold=3.97) & TIA1 & A2 TIA1 T1A2 .
    [Show full text]
  • Mechanical Forces Induce an Asthma Gene Signature in Healthy Airway Epithelial Cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T
    www.nature.com/scientificreports OPEN Mechanical forces induce an asthma gene signature in healthy airway epithelial cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T. Kho4, Kelan Tantisira1, Marc Santolini 1,5, Feixiong Cheng6,7,8, Jennifer A. Mitchel3, Maureen McGill3, Michael J. O’Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H. Randell9, Jefrey M. Drazen3, Jefrey J. Fredberg3 & Scott T. Weiss1,3* Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufcient to induce infammatory, late repair, and fbrotic pathways. Remarkably, this molecular profle of non-asthmatic cells after compression recapitulated the profle of asthmatic cells before compression. Together, these results show that even in the absence of any infammatory stimulus, mechanical compression alone is sufcient to induce an asthma-like molecular signature. Bronchial epithelial cells (BECs) form a physical barrier that protects pulmonary airways from inhaled irritants and invading pathogens1,2. Moreover, environmental stimuli such as allergens, pollutants and viruses can induce constriction of the airways3 and thereby expose the bronchial epithelium to compressive mechanical stress. In BECs, this compressive stress induces structural, biophysical, as well as molecular changes4,5, that interact with nearby mesenchyme6 to cause epithelial layer unjamming1, shedding of soluble factors, production of matrix proteins, and activation matrix modifying enzymes, which then act to coordinate infammatory and remodeling processes4,7–10.
    [Show full text]
  • Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-Cell Leukemia
    Author Manuscript Published OnlineFirst on March 27, 2020; DOI: 10.1158/1078-0432.CCR-19-3519 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia Anouchka P. Laurent1,2, Aurélie Siret1, Cathy Ignacimouttou1, Kunjal Panchal3, M’Boyba K. Diop4, Silvia Jenny5, Yi-Chien Tsai5, Damien Ross-Weil1, Zakia Aid1, Naïs Prade6, Stéphanie Lagarde6, Damien Plassard7, Gaelle Pierron8, Estelle Daudigeos-Dubus4, Yann Lecluse4, Nathalie Droin1, Beat Bornhauser5, Laurence C. Cheung3,9, John D. Crispino10, Muriel Gaudry1, Olivier A. Bernard1, Elizabeth Macintyre11, Carole Barin Bonnigal12, Rishi S. Kotecha3,9,13, Birgit Geoerger4, Paola Ballerini14, Jean-Pierre Bourquin5, Eric Delabesse6, Thomas Mercher1,15 and Sébastien Malinge1,3 1INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France 2Université Paris Diderot, Paris, France 3Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia 4Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale contre le Cancer, Université Paris-Saclay, Villejuif, France 5Department of Pediatric Oncology, Children’s Research Centre, University Children’s Hospital Zurich, Zurich, Switzerland 6Centre of Research on Cancer of Toulouse (CRCT), CHU Toulouse, Université Toulouse III, Toulouse, France 7IGBMC, Plateforme GenomEast, UMR7104 CNRS, Ilkirch, France 8Service de Génétique, Institut Curie, Paris, France 9School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Australia 10Division of Hematology/Oncology, Northwestern University, Chicago, USA 11Hematology, Université de Paris, Institut Necker-Enfants Malades and Assistance Publique – Hopitaux de Paris, Paris, France 12Centre Hospitalier Universitaire de Tours, Tours, France 1 Downloaded from clincancerres.aacrjournals.org on September 30, 2021.
    [Show full text]
  • Gentaur Products List
    Chapter 2 : Gentaur Products List • Rabbit Anti LAMR1 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Podoplanin gp36 Polyclonal Antibody Cy5 • Rabbit Anti LAMR1 CT Polyclonal Antibody Cy5 • Rabbit Anti phospho NFKB p65 Ser536 Polyclonal Conjugated Conjugated Antibody Cy5 Conjugated • Rabbit Anti CHRNA7 Polyclonal Antibody Cy5 Conjugated • Rat Anti IAA Monoclonal Antibody Cy5 Conjugated • Rabbit Anti EV71 VP1 CT Polyclonal Antibody Cy5 • Rabbit Anti Connexin 40 Polyclonal Antibody Cy5 • Rabbit Anti IAA Indole 3 Acetic Acid Polyclonal Antibody Conjugated Conjugated Cy5 Conjugated • Rabbit Anti LHR CGR Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Integrin beta 7 Polyclonal Antibody Cy5 • Rabbit Anti Natrexone Polyclonal Antibody Cy5 Conjugated • Rabbit Anti MMP 20 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Melamine Polyclonal Antibody Cy5 Conjugated • Rabbit Anti BCHE NT Polyclonal Antibody Cy5 Conjugated • Rabbit Anti NAP1 NAP1L1 Polyclonal Antibody Cy5 • Rabbit Anti Acetyl p53 K382 Polyclonal Antibody Cy5 • Rabbit Anti BCHE CT Polyclonal Antibody Cy5 Conjugated Conjugated Conjugated • Rabbit Anti HPV16 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti CCP Polyclonal Antibody Cy5 Conjugated • Rabbit Anti JAK2 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HPV18 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HDC Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Microsporidia protien Polyclonal Antibody Cy5 • Rabbit Anti HPV16 E7 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Neurocan Polyclonal
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • Chromosomal Assignment of the Genes for Human Aldehyde Dehydrogenase-1 and Aldehyde Dehydrogenase-2 LILY C
    Am J Hum Genet 38:641-648, 1986 Chromosomal Assignment of the Genes for Human Aldehyde Dehydrogenase-1 and Aldehyde Dehydrogenase-2 LILY C. Hsu,', AKIRA YOSHIDA,' AND T. MOHANDAS2 SUMMARY Chromosomal assignment of the genes for two major human aldehyde dehydrogenase isozymes, that is, cytosolic aldehyde dehydrogenase-1 (ALDH1) and mitochondrial aldehyde dehydrogenase-2 (ALDH2) were determined. Genomic DNA, isolated from a panel of mouse- human and Chinese hamster-human hybrid cell lines, was digested by restriction endonucleases and subjected to Southern blot hybridiza- tion using cDNA probes for ALDH1 and for ALDH2. Based on the distribution pattern of ALDH1 and ALDH2 in cell hybrids, ALDHI was assigned to the long arm of human chromosome 9 and ALDH2 to chromosome 12. INTRODUCTION Two major and at least two minor aldehyde dehydrogenase isozymes exist in human and other mammalian livers. One of the major isozymes, designated as ALDH 1, or E1, is of cytosolic origin, and another major isozyme, designated as ALDH2 or E2, is of mitochondrial origin. The two isozymes are different from each other with respect to their kinetic properties, sensitivity to disulfiram inactivation, and protein structure [1-5]. Remarkable racial differences be- tween Caucasians and Orientals have been found in these isozymes. Approxi- mately 50% of Orientals have a variant form of ALDH2 associated with dimin- ished activity, while virtually all Caucasians have the wild-type active ALDH2 Received July 10, 1985; revised September 23, 1985. This work was supported by grant AA05763 from the National Institutes of Health. ' Department of Biochemical Genetics, Beckman Research Institute of the City of Hope, Duarte, CA 91010.
    [Show full text]
  • AK3L1 (AK4) Mouse Monoclonal Antibody [Clone ID: OTI3A9] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA503371 AK3L1 (AK4) Mouse Monoclonal Antibody [Clone ID: OTI3A9] Product data: Product Type: Primary Antibodies Clone Name: OTI3A9 Applications: FC, WB Recommended Dilution: WB 1:2000, FLOW 1:100 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG2b Clonality: Monoclonal Immunogen: Full length human recombinant protein of human AK4(NP_037542) produced in HEK293T cell. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 1 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 25.1 kDa Gene Name: adenylate kinase 4 Database Link: NP_037542 Entrez Gene 11639 MouseEntrez Gene 29223 RatEntrez Gene 205 Human P27144 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 AK3L1 (AK4) Mouse Monoclonal Antibody [Clone ID: OTI3A9] – TA503371 Background: This gene encodes a member of the adenylate kinase family of enzymes. The encoded protein is localized to the mitochondrial matrix. Adenylate kinases regulate the adenine and guanine nucleotide compositions within a cell by catalyzing the reversible transfer of phosphate group among these nucleotides. Five isozymes of adenylate kinase have been identified in vertebrates.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • ARTICLE Doi:10.1038/Nature10523
    ARTICLE doi:10.1038/nature10523 Spatio-temporal transcriptome of the human brain Hyo Jung Kang1*, Yuka Imamura Kawasawa1*, Feng Cheng1*, Ying Zhu1*, Xuming Xu1*, Mingfeng Li1*, Andre´ M. M. Sousa1,2, Mihovil Pletikos1,3, Kyle A. Meyer1, Goran Sedmak1,3, Tobias Guennel4, Yurae Shin1, Matthew B. Johnson1,Zˇeljka Krsnik1, Simone Mayer1,5, Sofia Fertuzinhos1, Sheila Umlauf6, Steven N. Lisgo7, Alexander Vortmeyer8, Daniel R. Weinberger9, Shrikant Mane6, Thomas M. Hyde9,10, Anita Huttner8, Mark Reimers4, Joel E. Kleinman9 & Nenad Sˇestan1 Brain development and function depend on the precise regulation of gene expression. However, our understanding of the complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and analysis of exon-level transcriptome and associated genotyping data, representing males and females of different ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We found that 86 per cent of the genes analysed were expressed, and that 90 per cent of these were differentially regulated at the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences were detected before birth, with subsequent increases in the similarity among regional transcriptomes. The transcriptome is organized into distinct co-expression networks, and shows sex-biased gene expression and exon usage. We also profiled trajectories of genes associated with neurobiological categories and diseases, and identified associations between single nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain transcriptome and insights into the transcriptional foundations of human neurodevelopment.
    [Show full text]
  • The Characterization of Human Adenylate Kinases 7 and 8
    The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes Christakis Panayiotou, Nicola Solaroli, Yunjian Xu, Magnus Johansson, Anna Karlsson To cite this version: Christakis Panayiotou, Nicola Solaroli, Yunjian Xu, Magnus Johansson, Anna Karlsson. The char- acterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes. Biochemical Journal, Port- land Press, 2011, 433 (3), pp.527-534. 10.1042/BJ20101443. hal-00558097 HAL Id: hal-00558097 https://hal.archives-ouvertes.fr/hal-00558097 Submitted on 21 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Biochemical Journal Immediate Publication. Published on 16 Nov 2010 as manuscript BJ20101443 The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes
    [Show full text]
  • Phylogenetic Analysis, Subcellular Localization, and Expression
    BMC Plant Biology BioMed Central Research article Open Access Phylogenetic analysis, subcellular localization, and expression patterns of RPD3/HDA1 family histone deacetylases in plants Malona V Alinsug, Chun-Wei Yu and Keqiang Wu* Address: Institute of Plant Biology, College of Life Science, National Taiwan University, Taipei, Taiwan Email: Malona V Alinsug - [email protected]; Chun-Wei Yu - [email protected]; Keqiang Wu* - [email protected] * Corresponding author Published: 28 March 2009 Received: 26 November 2008 Accepted: 28 March 2009 BMC Plant Biology 2009, 9:37 doi:10.1186/1471-2229-9-37 This article is available from: http://www.biomedcentral.com/1471-2229/9/37 © 2009 Alinsug et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Although histone deacetylases from model organisms have been previously identified, there is no clear basis for the classification of histone deacetylases under the RPD3/ HDA1 superfamily, particularly on plants. Thus, this study aims to reconstruct a phylogenetic tree to determine evolutionary relationships between RPD3/HDA1 histone deacetylases from six different plants representing dicots with Arabidopsis thaliana, Populus trichocarpa, and Pinus taeda, monocots with Oryza sativa and Zea mays, and the lower plants with Physcomitrella patens. Results: Sixty two histone deacetylases of RPD3/HDA1 family from the six plant species were phylogenetically analyzed to determine corresponding orthologues. Three clusters were formed separating Class I, Class II, and Class IV.
    [Show full text]